(S (NP-SBJ-7 (NP Activity/NN) (PP of/IN (NP (NP the/DT kappa/NN B/NN enhancer/NN) (PP of/IN (NP the/DT interleukin-2/NN receptor/NN alpha/NN chain/NN)))) (PP in/IN (NP somatic/JJ cell/NN hybrids/NNS))) (VP is/VBZ (VP accompanied/VBN (NP *-7/-NONE-) (PP by/IN (NP-LGS (NP the/DT nuclear/JJ localization/NN) (PP of/IN (NP NF-kappa/NN B/NN)))))) ./.)
(S (NP-SBJ-COOD-8 (NP (NP The/DT two/CD nuclear/JJ proteins/NNS NF-kappa/NN B/NN) -LRB-/-LRB- (VP consisting/VBG (PP of/IN (NP subunits/NNS (NP-COOD (NP p50/NN) and/CC (NP p65/NN))))) -RRB-/-RRB-) and/CC (NP (NP (NP the/DT DNA-binding/JJ subunit/NN) (PP of/IN (NP (NP NF-kappa/NN B/NN) (PRN -LRB-/-LRB- (NP p50/NN) -RRB-/-RRB-))) (PP by/IN (NP itself/PRP))) ,/, (VP (ADVP also/RB) called/VBN (S (NP-SBJ */-NONE-) (NP-PRD KBF1/NN)))) ,/,) (VP are/VBP (ADVP constitutively/RB) (VP (VP-COOD (VP expressed/VBN (NP-9 *-8/-NONE-)) and/CC (VP localized/JJ (NP *-9/-NONE-))) (PP in/IN (NP the/DT nucleus/NN) (PP of/IN (NP the/DT human/JJ T-cell/NN line/NN IARC/NN 301.5/CD))))) ./.)
(S (SBAR-ADV In/IN order/NN to/TO (S (NP-SBJ *-10/-NONE-) (VP define/VB (NP (NP the/DT roles/NNS) (PP of/IN (NP (NP these/DT two/CD factors/NNS) ,/, (SBAR (WHNP-11 which/WDT) (S (NP-SBJ *T*-11/-NONE-) (VP bind/VBP (PP to/TO (NP the/DT same/JJ kappa/NN B/NN enhancers/NNS))))))))))) ,/, (PP in/IN (NP transcription/NN activation/NN)) (NP-SBJ-10 we/PRP) (VP have/VBP (VP prepared/VBN (NP (NP somatic/JJ cell/NN hybrids/NNS) (PP between/IN (NP-COOD (NP IARC/NN 301.5/CD) and/CC (NP a/DT murine/JJ myeloma/NN)))))) ./.)
(S-COOD (S (NP-SBJ Most/JJS hybrids/NNS) (VP express/VBP (NP-COOD both/CC (NP KBF1/NN) and/CC (NP NF-kappa/NN B/NN)) (PP in/IN (NP their/PRP$ nuclei/NNS)))) ,/, but/CC (S (NP-SBJ one/CD hybrid/NN) (VP expresses/VBZ (NP only/RB KBF1/NN))) ./.)
(S (NP-SBJ (NP The/DT kappa/NN B/NN enhancer/NN) (PP of/IN (NP (NP the/DT gene/NN) (VP encoding/VBG (NP (NP the/DT (NP (NP interleukin-2/NN) (PRN -LRB-/-LRB- (NP IL-2/NN) -RRB-/-RRB-)) receptor/NN alpha/NN chain/NN) (PRN -LRB-/-LRB- (NP IL-2R/NN alpha/NN) -RRB-/-RRB-)))))) (VP is/VBZ (ADJP-PRD functional/JJ) (PP only/RB in/IN (NP (NP the/DT hybrids/NNS) (VP expressing/VBG (NP nuclear/JJ NF-kappa/NN B/NN))))) ./.)
(S (NP-SBJ These/DT findings/NNS) (VP show/VBP (SBAR that/IN (S (NP-SBJ-12 nuclear/JJ NF-kappa/NN B/NN) (VP is/VBZ (ADJP-PRD necessary/JJ (S (NP-SBJ *-12/-NONE-) (VP to/TO (VP activate/VB (NP the/DT kappa/NN B/NN enhancer/NN))))) ,/, (SBAR while/IN (S (NP-SBJ (NP KBF1/NN) (PP by/IN (NP itself/PRP))) (VP is/VBZ not/RB (ADJP-PRD sufficient/JJ)))))))) ./.)
(S (NP-SBJ We/PRP) (VP-COOD (VP propose/VBP (SBAR that/IN (S (NP-SBJ KBF1/NN) (VP is/VBZ (NP-PRD (NP a/DT competitive/JJ inhibitor/NN) (PP of/IN (NP NF-kappa/NN B/NN))))))) and/CC (VP discuss/VB (SBAR (WHADVP-13 how/WRB) (S (NP-SBJ-14 these/DT factors/NNS) (VP may/MD (VP be/VB (VP involved/VBN (NP *-14/-NONE-) (PP in/IN (NP (NP the/DT transient/JJ expression/NN) (PP of/IN (NP (NP-COOD (NP IL-2/NN) and/CC (NP IL-2/NN alpha/NN)) genes/NNS)) (PP-TMP during/IN (NP the/DT immune/JJ response/NN)))) (ADVP *T*-13/-NONE-)))))))) ./.)
